Red hot preview coming to you today, as we’re soon to launch our new Media Vitals Global HCP report, offering insights around ...

One-size-fits-all doesn’t fit – in today’s global marketplace, personalization is the best way to engage key audiences. In ...

Novo Nordisk and Gensaic have entered into a partnership worth up to $354m to develop new therapies for cardiometabolic ...

Eli Lilly’s Jaypirca (pirtobrutinib) has been recommended by the European Medicines Agency’s (EMA) human medicines committee ...

Regeneron Pharmaceuticals has received a positive opinion from the European Medicines Agency’s human medicines committee for ...

The Healthcare Communications Association has recently revitalised its long-established efforts to evaluate impact (those of ...

One of the toughest challenges of educating many African women about female cancers and disease prevention is overcoming ...

Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has been approved by the Medicines and Healthcare products ...

Roche’s Genentech unit has received approval from the US Food and Drug Administration (FDA) for TNKase (tenecteplase) in ...

BeiGene’s Tevimbra (tislelizumab-jsgr) has been approved by the US Food and Drug Administration (FDA) as part of a first-line ...

Luto, a patient-centred healthcare communications agency, has announced the opening of a new office in Basel, Switzerland, ...

But ineffective marketing is, in the words of one CEO I interviewed, a ‘wombat’; a waste of money, brains and time that ...